VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,475,260 | -8.7% | 54,822 | +2.1% | 0.05% | -16.4% |
| Q2 2023 | $1,616,485 | -17.9% | 53,686 | -11.8% | 0.06% | -29.5% |
| Q1 2023 | $1,969,803 | +31.9% | 60,890 | +16.8% | 0.08% | +2.6% |
| Q4 2022 | $1,493,676 | +256.5% | 52,117 | +200.2% | 0.08% | +216.7% |
| Q3 2022 | $419,000 | -17.4% | 17,358 | -6.3% | 0.02% | -17.2% |
| Q2 2022 | $507,000 | -23.6% | 18,533 | +7.0% | 0.03% | -12.1% |
| Q1 2022 | $664,000 | +3.1% | 17,314 | -13.8% | 0.03% | +6.5% |
| Q4 2021 | $644,000 | +1.4% | 20,092 | -6.8% | 0.03% | -11.4% |
| Q3 2021 | $635,000 | -9.2% | 21,557 | +4.9% | 0.04% | -18.6% |
| Q2 2021 | $699,000 | +2.3% | 20,557 | -2.2% | 0.04% | -10.4% |
| Q1 2021 | $683,000 | -10.8% | 21,009 | +0.2% | 0.05% | -14.3% |
| Q4 2020 | $766,000 | -99.9% | 20,961 | -24.2% | 0.06% | -40.4% |
| Q3 2020 | $1,082,000,000 | – | 27,649 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
| Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
| Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
| New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
| Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
| Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
| Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
| Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
| Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |